Background illustration for clinical trials search

Paid Clinical Trials Newnan

Discover 1,605 paid clinical trials in Newnan, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Atlanta GA, Macon GA, Birmingham AL, Louisville KY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06947993

Phase2, Recruiting

Arginine Replacement Therapy in COVID-19

for
COVID-19
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 3 - 21

Code: NCT05855330

Phase2, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

for
Multiple Myeloma
Location: Atlanta GA, Charlotte NC, Winston-Salem NC,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06892522

Phase1, Phase2, Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

for
Locally Advanced Solid Tumors, Metastatic Solid Tumors,
Location: Atlanta GA, Charlotte NC, Memphis TN, St Louis MO,
Sponsor: Turning Point Therapeutics, Inc.

Sex: All

Age: 0 - 25

Code: NCT04094610

Phase1, Phase2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Atlanta GA, Birmingham AL, Greenville SC, Knoxville TN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Atlanta GA, Macon GA, Birmingham AL, Greenville SC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: Atlanta GA, Birmingham AL, Greenville SC, Knoxville TN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Atlanta GA, Birmingham AL, Greenville SC, Knoxville TN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase2, Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Atlanta GA, Birmingham AL, Knoxville TN, Nashville TN,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT07022678

Phase3, Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Atlanta GA, Memphis TN, Durham NC, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 39

Code: NCT04616560

Phase2, Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

for
Metastatic Ewing Sarcoma
Location: Atlanta GA, Birmingham AL, Nashville TN,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 1+

Code: NCT07194044

Phase1, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Atlanta GA, Birmingham AL, Greenville SC, Knoxville TN,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Atlanta GA, Birmingham AL, Knoxville TN, Asheville NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Atlanta GA, Birmingham AL, Memphis TN, Durham NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase1, Phase2, Recruiting

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

for
Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
Location: Smyrna GA, Snellville GA, Jacksonville FL,
Sponsor: Coologics, Inc

Sex: Female

Age: 22 - 49

Code: NCT06983041

Recruiting

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

for
Immunoglobulin A Nephropathy (IgAN)
Location: Acworth GA, Iowa City IA, Edina MN, Denver CO
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07146906

Phase2, Recruiting

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

for
Glanzmann Thrombasthenia
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 0+

Code: NCT07136857

Phase2, Recruiting

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

for
Status Epilepticus
Location: Atlanta GA, Orlando FL, Cincinnati OH, Indianapolis IN,
Sponsor: University of Virginia

Sex: All

Age: 1+

Code: NCT06907173

Phase3, Recruiting

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

for
Sickle Cell Disease
Location: Atlanta GA, Flowood MS, Little Rock AR, Columbus OH,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07224360

Phase2, Recruiting

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

for
Sickle Cell Disease Vaso-occlusive Crisis
Location: Atlanta GA, Louisville KY, Cincinnati OH, Greenville NC,
Sponsor: CSL Behring

Sex: All

Age: 12+

Code: NCT06699849

Phase2, Recruiting